BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 12, 2019
View Archived Issues
Naive B cells have tell-tale signature in lupus
Read More
UCB studies rozanolixizumab in phase III for generalized myasthenia gravis
Read More
Pact Pharma initiates first-in-human study of NeoTCR-P1 in solid tumors
Read More
Pfizer initiates phase II study of PF-06826647 for the treatment of plaque psoriasis
Read More
Patient recruitment ongoing in phase I study of CPI-200
Read More
mR-21 as potential prognostic biomarker and therapeutic target in hypertensive heart disease
Read More
[89Zr]-Daratumumab as a promising new agent for CD38-targeted imaging of myeloma
Read More
Tracer quantification and assessment of tumor uptake of [18F]afatinib in NSCLC
Read More
NDFIP1 may be a novel target for prevention and treatment of Parkinson's disease
Read More
CEPI and WBVR partner on vaccine for Rift Valley fever
Read More
Hydra's opposite: researchers identify broad resistance mechanism to narrowly targeted therapies
Read More
Lundbeck describes new PDE1 inhibitors
Read More
New adenosine A2A receptor antagonists presented by Adorx Therapeutics
Read More
NodThera discovers NLRP3 inflammasome inhibitors
Read More
Roche discloses new gamma-secretase inhibitors
Read More
ReViral patents respiratory syncytial virus fusion inhibitors
Read More
New genetic variants found in individuals with disorders of sexual development
Read More
FDA clears HOOKIPA's IND for phase I/II trial of HB-201 for HPV-positive cancers
Read More
Novartis and Amgen discontinue pivotal studies of CNP-520 for Alzheimer's disease
Read More
Interim phase Ib data on ACI-24 to treat Alzheimer's disease-like symptoms in Down syndrome
Read More
New hamster model of carotid artery atherothrombotic occlusion developed
Read More
Faron offers update from phase I/II MATINS study of Clevegen in advanced solid tumors
Read More
First patient enrolled in phase I study of GST-HG-161
Read More
Study in humans determines biodistribution of COX-1 PET radioligand [11C]PS-13
Read More
Beta Pharma enrolling patients with NSCLC for phase III trial of BPI-7711
Read More
Human biodistribution and dosimetry of the PET imaging agent [11C]trimethoprim
Read More